These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3514302)

  • 1. Use of donor-specific T-cell lines for monitoring of human allograft recipients. I. Demonstration of IgG binding to autologous TCL.
    Huber C; Irschik E; Leiter E; Binz H; Niederwieser D; Spielberger M; Kathrein H; Schönitzer D; Margreiter R
    Exp Cell Biol; 1986; 54(1):16-24. PubMed ID: 3514302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and specificity of anti-B lymphocyte antibodies in renal allograft recipients.
    Fauchet R; Genetet B; Campion JP; Watelet J; Minet J; Cartier F; Launois B
    Transplantation; 1980 Aug; 30(2):114-7. PubMed ID: 7010705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperacute renal allograft rejection from anti-HLA class 1 antibody to B cells--antibody detection by two color FCXM was possible only after using pronase-digested donor lymphocytes.
    Lobo PI; Spencer CE; Isaacs RB; McCullough C
    Transpl Int; 1997; 10(1):69-73. PubMed ID: 9002156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft.
    Böhmig GA; Regele H; Säemann MD; Exner M; Druml W; Kovarik J; Hörl WH; Zlabinger GJ; Watschinger B
    Am J Kidney Dis; 2000 Apr; 35(4):667-73. PubMed ID: 10739788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejection of a kidney transplant does not always lead to priming of cytotoxic T cells against mismatched donor HLA class I antigens.
    van Kampen CA; Versteeg-van der Voort Maarschalk MF; Roelen DL; ten Berge IJ; Claas FH
    Transplantation; 2001 Apr; 71(7):869-74. PubMed ID: 11349718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence demonstrating poor kidney graft survival when acute rejections are associated with IgG donor-specific lymphocytotoxin.
    Lobo PI; Spencer CE; Stevenson WC; Pruett TL
    Transplantation; 1995 Feb; 59(3):357-60. PubMed ID: 7871565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic T lymphocytes directed against donor HLA class I antigens on airway epithelial cells are present in bronchoalveolar lavage fluid from lung transplant recipients during acute rejection.
    Nakajima J; Poindexter NJ; Hillemeyer PB; Trulock EP; Cooper JD; Patterson GA; Mohanakumar T; Sundaresan RS
    J Thorac Cardiovasc Surg; 1999 Mar; 117(3):565-71. PubMed ID: 10047661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An apparent paradoxical effect of pretransplant blood transfusions. Its association with decreased anti-HLA antibody formation following unsuccessful renal transplantation.
    Lobo PI
    Transplantation; 1984 Jun; 37(6):562-4. PubMed ID: 6375015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell role in renal allograft rejection and regulation. Renal allograft infiltrating cytotoxic T-cell line with suppressor-inducer function.
    Emara MA; Mozes MF
    Hum Immunol; 1995 Feb; 42(2):161-73. PubMed ID: 7744620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection.
    Supon P; Constantino D; Hao P; Cagle L; Hahn A; Conti DJ; Freed BM
    Transplantation; 2001 Feb; 71(4):577-80. PubMed ID: 11258441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of lymphocytotoxic antibodies by pretransplant immunoadsorption therapy in highly sensitized renal transplant recipients.
    Kupin WL; Venkat KK; Hayashi H; Mozes MF; Oh HK; Watt R
    Transplantation; 1991 Feb; 51(2):324-9. PubMed ID: 1994523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.